These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15387129)

  • 61. Outcomes of kidney transplantation from older living donors to older recipients.
    Gill J; Bunnapradist S; Danovitch GM; Gjertson D; Gill JS; Cecka M
    Am J Kidney Dis; 2008 Sep; 52(3):541-52. PubMed ID: 18653267
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004.
    Gruessner AC; Sutherland DE
    Clin Transplant; 2005 Aug; 19(4):433-55. PubMed ID: 16008587
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of donor age on renal allograft function and survival.
    Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
    Transplant Proc; 2009 Apr; 41(3):794-6. PubMed ID: 19376354
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transplantation of single pediatric kidneys into adult recipients.
    Csapo Z; Knight RJ; Podder H; Kerman RH; Schoenberg L; Katz SM; Van Buren CT; Kahan BD
    Transplant Proc; 2005 Mar; 37(2):697-8. PubMed ID: 15848505
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Simultaneous pancreas-kidney versus deceased donor kidney transplant: can a fair comparison be made?
    Weiss AS; Smits G; Wiseman AC
    Transplantation; 2009 May; 87(9):1402-10. PubMed ID: 19424043
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Living donor renal transplantation in Catalonia: overall results and comparison of survival with cadaveric donor renal transplantation.
    García-Maset R; Perich LG; Vallespin EV; Escayola MC; Gómez JM; Puigjaner RS;
    Transplant Proc; 2005 Nov; 37(9):3682-3. PubMed ID: 16386504
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
    Lachmann N; Terasaki PI; Schönemann C
    Clin Transpl; 2006; ():171-99. PubMed ID: 18365377
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sensitization 2001.
    Hardy S; Lee SH; Terasaki PI
    Clin Transpl; 2001; ():271-8. PubMed ID: 12211790
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Waiting time and outcome of kidney transplantation in adolescents.
    Kennedy SE; Mackie FE; Rosenberg AR; McDonald SP
    Transplantation; 2006 Oct; 82(8):1046-50. PubMed ID: 17060853
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
    Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database.
    Chavalitdhamrong D; Gill J; Takemoto S; Madhira BR; Cho YW; Shah T; Bunnapradist S
    Transplantation; 2008 Jun; 85(11):1573-9. PubMed ID: 18551062
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kidney transplantation in children and adolescents: an analysis of United Network for Organ Sharing Database.
    Hardy BE; Shah T; Cicciarelli J; Lemley KV; Hutchinson IV; Cho YW
    Transplant Proc; 2009 Jun; 41(5):1533-5. PubMed ID: 19545673
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A third renal transplantation: is it relevant and is it worth it?
    Reboux AH; Kamar N; Fort M; Rischmann P; Malavaud B; Cointault O; Abbal M; Durand D; Rostaing L
    Transplant Proc; 2005 Dec; 37(10):4199-202. PubMed ID: 16387077
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors.
    Shaw BE; Russell NH; Devereux S; Das-Gupta E; Mackinnon S; Madrigal JA; Pagliuca A; Mufti GJ; Byrne JL
    Haematologica; 2005 Nov; 90(11):1562-9. PubMed ID: 16266905
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predictive factors for immunologic graft failure in cadaver renal transplant recipients.
    Pirsch JD; Voss BJ; Roecker EB; Lorentzen DF; Knechtle SJ; Reed A; D'Alessandro AM; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1282-3. PubMed ID: 1989213
    [No Abstract]   [Full Text] [Related]  

  • 76. Planned third-party transfusions prior to first transplantations from liver related donors.
    Brynger H; Frisk B; Larsson O; Sandberg L
    Scand J Urol Nephrol Suppl; 1981; 64():152-6. PubMed ID: 6755674
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Current challenges in renal transplantation from deceased donors.
    Salmela K; Kyllönen L
    Clin Transpl; 2007; ():61-7. PubMed ID: 18637459
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Survival benefits of kidney transplantation with expanded criteria deceased donors in patients aged 60 years and over.
    Savoye E; Tamarelle D; Chalem Y; Rebibou JM; Tuppin P
    Transplantation; 2007 Dec; 84(12):1618-24. PubMed ID: 18165773
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Bergamo Kidney Transplant Program.
    Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
    Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Center effect.
    Mickey MR
    Clin Transpl; 1986; ():165-73. PubMed ID: 3154395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.